Suven Pharmaceuticals Ltd. had a revenue of 3.07B in the quarter ending Dec 31, 2024, with 19.18%. This bring the company's revenue in the last twelve months to 10.48B, Decreased 9.09%. In the fiscal year ending Mar 31, 2024, Suven Pharmaceuticals Ltd. had annual revenue of 10.51B with -21.56% growth.